C Cachera

635 total citations
26 papers, 496 citations indexed

About

C Cachera is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, C Cachera has authored 26 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 10 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Molecular Biology. Recurrent topics in C Cachera's work include Lipoproteins and Cardiovascular Health (13 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). C Cachera is often cited by papers focused on Lipoproteins and Cardiovascular Health (13 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). C Cachera collaborates with scholars based in France and Russia. C Cachera's co-authors include A Tacquet, M Dracon, Jean‐Charles Fruchart, H J Parra, J C Fruchart, Hafid Mezdour, V. Clavey, A. Kandoussi, Y Moschetto and Patrick Duthilleul and has published in prestigious journals such as Biochemical Journal, Kidney International and The American Journal of Cardiology.

In The Last Decade

C Cachera

26 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Cachera France 11 300 250 117 95 87 26 496
D. Erlich France 12 411 1.4× 143 0.6× 91 0.8× 122 1.3× 98 1.1× 22 630
George Miltiadous Greece 15 415 1.4× 287 1.1× 114 1.0× 125 1.3× 63 0.7× 39 702
J.W. Persaud United Kingdom 15 194 0.6× 189 0.8× 82 0.7× 31 0.3× 171 2.0× 20 470
M. Ishola United Kingdom 11 507 1.7× 504 2.0× 188 1.6× 145 1.5× 88 1.0× 16 850
Keane Wf United States 12 183 0.6× 136 0.5× 138 1.2× 49 0.5× 304 3.5× 18 617
C B Marenah United Kingdom 17 289 1.0× 167 0.7× 76 0.6× 60 0.6× 68 0.8× 30 670
M Liron Israel 10 157 0.5× 204 0.8× 155 1.3× 51 0.5× 28 0.3× 27 483
Jiri Frohlich Canada 7 391 1.3× 111 0.4× 61 0.5× 82 0.9× 43 0.5× 13 596
J. Frohlich Canada 16 538 1.8× 388 1.6× 177 1.5× 159 1.7× 46 0.5× 33 887
Shinichi Mashiba Japan 15 155 0.5× 146 0.6× 105 0.9× 54 0.6× 138 1.6× 20 516

Countries citing papers authored by C Cachera

Since Specialization
Citations

This map shows the geographic impact of C Cachera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Cachera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Cachera more than expected).

Fields of papers citing papers by C Cachera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Cachera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Cachera. The network helps show where C Cachera may publish in the future.

Co-authorship network of co-authors of C Cachera

This figure shows the co-authorship network connecting the top 25 collaborators of C Cachera. A scholar is included among the top collaborators of C Cachera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Cachera. C Cachera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kandoussi, A., C Cachera, Marc Hazzan, et al.. (1998). Apo(a) Phenotypes and Lp(a) Concentrations in Renal Transplant Patients. ˜The œNephron journals/Nephron journals. 80(2). 183–187. 5 indexed citations
2.
Mezdour, Hafid, et al.. (1996). Neutral-Lipid Transfers and Cholesteryl Ester Transfer Protein in Hemodialyzed Patients. American Journal of Nephrology. 16(5). 394–401. 5 indexed citations
3.
Kandoussi, A., Henri‐Joseph Parra, M Dracon, et al.. (1996). Apolipoprotein Al and Apolipoprotein B Containing Particle Analysis in Normolipidemic Hemodialyzed Patients: Evidence of Free Apolipoprotein E. American Journal of Nephrology. 16(4). 287–292. 3 indexed citations
4.
Parra, H J, et al.. (1996). Alteration of the lipid and apolipoprotein contents of lipoprotein (a) in haemodialysis patients. Nephrology Dialysis Transplantation. 11(5). 825–829. 5 indexed citations
5.
Tailleux, Anne, Richard Reade, C Cachera, et al.. (1993). Expression of apolipoprotein B epitopes in low density lipoproteins of hemodialyzed patients. Kidney International. 44(6). 1360–1365. 9 indexed citations
6.
Kandoussi, A., C Cachera, Dominique Pagniez, et al.. (1992). Plasma level of lipoprotein Lp(a) is high in predialysis or hemodialysis, but not in CAPD. Kidney International. 42(2). 424–425. 37 indexed citations
7.
Kandoussi, A., C Cachera, Richard Reade, et al.. (1992). Apo AIV in plasma and dialysate fluid of CAPD patients: Comparison with other apolipoproteins. Nephrology Dialysis Transplantation. 7(10). 1026–1029. 12 indexed citations
8.
9.
Saı̈le, Rachid, et al.. (1991). Quantification of serum amyloid P by enzyme-linked immunosorbent assay. Clinical Chemistry. 37(10). 1742–1745. 5 indexed citations
10.
Cachera, C, Jean‐Marie Bard, Philippe Amouyel, et al.. (1990). Lipoprotein particles in homozygous familial hypercholesterolemic patients treated with portacaval shunt and LDL apheresis. Clinica Chimica Acta. 193(3). 165–179. 4 indexed citations
11.
Reade, Richard, C Cachera, Patrick Duriez, et al.. (1989). Apolipoprotein B Immunochemical Heterogeneity in Dialysed Patients with Chronic Renal Failure and Patients with Coronary Artery Stenosis. American Journal of Nephrology. 9(2). 110–114. 4 indexed citations
12.
Agnani, G., Cyrille Delpierre, Soraya Benhamamouch, et al.. (1989). Antipeptide antibody against the human low-density-lipoprotein receptor. Characterization and cross-reactivity with bovine lymphocytes. Biochemical Journal. 263(3). 753–760. 1 indexed citations
13.
Parra, H J, et al.. (1988). Quantitative Abnormalities of Lipoprotein Particle in Chronic Hemodialysis Patients. Advances in experimental medicine and biology. 243. 283–287. 1 indexed citations
14.
Delpierre, Cyrille, Catherine Fiévet, Hafid Mezdour, et al.. (1988). Antibodies of predetermined specificity to apolipoprotein C-II elicited with a synthetic peptide. Journal of Immunological Methods. 109(1). 61–68. 3 indexed citations
15.
Barkia, Ahmed, Pascal Puchois, J. C. Gesquière, et al.. (1988). Enzyme-linked immunosorbent assay for human proapolipoprotein A-I using specific antibodies against synthetic peptide.. Journal of Lipid Research. 29(1). 77–84. 14 indexed citations
16.
Delpierre, Cyrille, César B. Gutiérrez‐Martín, J. C. Gesquière, et al.. (1987). Chemical approach to synthetic immunogens in clinical chemistry. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 14(4). 281–288. 1 indexed citations
17.
Parra, H J, et al.. (1984). [Assay of serum apolipoprotein A-II by electro-immunodiffusion on ready-for-use plates. Clinical applications].. PubMed. 42(5). 349–53. 5 indexed citations
18.
Fruchart, Jean‐Charles, et al.. (1982). Lipoproteins, apolipoproteins and coronary artery disease. La Ricerca in Clinica e in Laboratorio. 12(1). 101–106. 7 indexed citations
19.
Fruchart, Jean Charles, et al.. (1982). Lipoproteins, apolipoproteins and coronary artery disease assessed by coronary arteriography. The American Journal of Cardiology. 49(4). 984–984. 13 indexed citations
20.
Fruchart, Jean‐Charles, et al.. (1982). Simultaneous measurement of plasma apolipoproteins A-I and B by electroimmunoassay.. Clinical Chemistry. 28(1). 59–62. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Erlich Breakdown of academic impact, for papers by George Miltiadous Breakdown of academic impact, for papers by J.W. Persaud Breakdown of academic impact, for papers by M. Ishola Breakdown of academic impact, for papers by Keane Wf Breakdown of academic impact, for papers by C B Marenah Breakdown of academic impact, for papers by M Liron Breakdown of academic impact, for papers by Jiri Frohlich Breakdown of academic impact, for papers by J. Frohlich Breakdown of academic impact, for papers by Shinichi Mashiba
Rankless by CCL
2026